Trial intelligence / Profile preview

LCP-Tacro vs Prograf PK in Stable Liver Transplant

NCT00608244Phase 2Completed

Sponsor
Veloxis Pharmaceuticals
Start
Nov 2007
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Veloxis Pharmaceuticals. Started Nov 2007; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00608244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00608244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call